The aim of this thesis is to evaluate conventional and novel biomarkers on their performance to assess graft quality and predict outcome in LT.

The rising incidence of severe complications like NAS, which is strongly related to DCD, urges for predictive biomarkers in an earlier phase of LT. For example during graft preservation and by identifying recipients or donors with an increased risk for complications.

J.N.M. IJzermans (Jan) , H.J. Metselaar (Herold) , L.J.W. van der Laan (Luc)
Erasmus University Rotterdam
Printing of this thesis was supported by: Erasmus Universiteit Rotterdam, Erasmus MC – afdeling Heelkunde, Nederlandse Transplantatie Vereniging, Nederlandse Vereniging voor Hepatologie, Olympus Nederland B.V., Organ Assist, Chipsoft
Department of Surgery

Verhoeven, R. (2016, October 26). Biomarkers to assess graft quality in liver transplantation. Retrieved from